Expertise in
2
conditions

Dr. Naval G. Parikh

Internal Medicine
John B. Crescitelli D.O. P.A.
1 W Sample Rd Ste 302, 
Deerfield Beach, FL 
Accepting New Patients
Offers Telehealth
18 Years of Experience
Expertise in
2
conditions
John B. Crescitelli D.O. P.A.
1 W Sample Rd Ste 302, 
Deerfield Beach, FL 

Overview

Naval Parikh is a primary care provider, practicing in Internal Medicine in Deerfield Beach, Florida. He has been practicing medicine for over 18 years.

Dr. Parikh is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Gangrene, Stroke, Gout, Gastrostomy, and Stent Placement.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 5 clinical trials. Dr. Parikh is currently accepting new patients.

Graduate Year

2008

Specialties

Internal Medicine

Licenses

Internal Medicine in FL

Hospital Affiliations

Broward Health North
Holy Cross Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
SelectHealth
  • HMO
  • POS
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

John B. Crescitelli D.O. P.A.
1 W Sample Rd Ste 302, Deerfield Beach, FL 33064

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 4, Open-Label, Multicenter, Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Trial of Intravenous KRYSTEXXA® (Pegloticase) Administered Every 4 Weeks With Co-Administration of Weekly Doses of Methotrexate in Patients With Uncontrolled Refractory Gout (FORWARD Open-Label [OL] Trial)
A Phase 4, Open-Label, Multicenter, Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Trial of Intravenous KRYSTEXXA® (Pegloticase) Administered Every 4 Weeks With Co-Administration of Weekly Doses of Methotrexate in Patients With Uncontrolled Refractory Gout (FORWARD Open-Label [OL] Trial)
Enrollment Status: Completed
Publish Date: May 19, 2026
Intervention Type: Biological, Drug
Study Drugs: Pegloticase, Methotrexate
Study Phase: Phase 4
A Phase 2, Randomized, Double-Blind, Comparator-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CRS3123 Compared With Oral Vancomycin in Adults With Clostridioides Difficile Infection
A Phase 2, Randomized, Double-Blind, Comparator-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CRS3123 Compared With Oral Vancomycin in Adults With Clostridioides Difficile Infection
Enrollment Status: Completed
Publish Date: March 27, 2026
Intervention Type: Drug
Study Drug: CRS3123
Study Phase: Phase 2
A Phase 4, Multicenter, Open-Label, Infusion Duration Study To Assess Safety, Tolerability and Efficacy of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate
A Phase 4, Multicenter, Open-Label, Infusion Duration Study To Assess Safety, Tolerability and Efficacy of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate
Enrollment Status: Completed
Publish Date: October 20, 2025
Intervention Type: Biological
Study Drugs: Pegloticase, MTX
Study Phase: Phase 4
A Phase 4, Multicenter, Open-label, Efficacy and Safety Trial of Pegloticase and Methotrexate Co-administered in Patients With Uncontrolled Gout Who Have Previously Received Pegloticase Monotherapy But Did Not Maintain a Serum Uric Acid Response
A Phase 4, Multicenter, Open-label, Efficacy and Safety Trial of Pegloticase and Methotrexate Co-administered in Patients With Uncontrolled Gout Who Have Previously Received Pegloticase Monotherapy But Did Not Maintain a Serum Uric Acid Response
Enrollment Status: Completed
Publish Date: June 27, 2024
Intervention Type: Drug, Biological
Study Drug: Pegloticase
Study Phase: Phase 4
CONSORTIUM - A Double-Blind Placebo-Controlled Phase 2 Study of VE303 for Prevention of Recurrent Clostridium (Clostridioides) Difficile Infection
CONSORTIUM - A Double-Blind Placebo-Controlled Phase 2 Study of VE303 for Prevention of Recurrent Clostridium (Clostridioides) Difficile Infection
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

2 Total Publications

Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial.
Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial.
Journal: Open forum infectious diseases
Published: June 26, 2023
Similar Doctors
Expertise in
52
conditions
Dr. David I. Levenson
Internal Medicine
Expertise in
52
conditions
Dr. David I. Levenson
Internal Medicine

Office

7301 W Palmetto Park Rd Ste 108B, 
Boca Raton, FL 
 (5.5 miles away)
561-391-4441
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Levenson is a primary care provider, practicing in Internal Medicine in Boca Raton, Florida. Dr. Levenson is highly rated in 52 conditions, according to our data. His clinical expertise encompasses Maturity Onset Diabetes of the Young, Sitosterolemia, Type 2 Diabetes (T2D), and Idiopathic Hypercalciuria. Dr. Levenson is currently accepting new patients.

Expertise in
28
conditions
Dr. Barry L. Davis
Internal Medicine
Expertise in
28
conditions
Dr. Barry L. Davis
Internal Medicine

Office

1601 Clint Moore Rd Ste 100, 
Boca Raton, FL 
 (9.6 miles away)
561-939-0200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Barry Davis is a primary care provider, practicing in Internal Medicine in Boca Raton, Florida. Dr. Davis is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Bronchiectasis, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), and Pneumonia. Dr. Davis is currently accepting new patients.

Expertise in
77
conditions
Dr. Mohamed Erritouni
Internal Medicine
Expertise in
77
conditions
Dr. Mohamed Erritouni
Internal Medicine

Office

5130 Linton Blvd Ste G6, 
Delray Beach, FL 
 (11.1 miles away)
561-501-4266
Languages Spoken:
English, Arabic, Creoles And Pidgins, French
See accepted insurances
Accepting New Patients

Mohamed Erritouni is a primary care provider, practicing in Internal Medicine in Delray Beach, Florida. Dr. Erritouni is highly rated in 77 conditions, according to our data. His clinical expertise encompasses Hospital-Acquired Pneumonia, Atypical Pneumonia, Lymphangitis, and Pneumonia. Dr. Erritouni is currently accepting new patients.

Frequently Asked Questions about Dr. Naval G. Parikh

How do I make an appointment with Dr. Naval G. Parikh?

You can book an appointment with Dr. Naval G. Parikh by calling their office at 954-933-7948. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Naval G. Parikh a top-rated expert for Gangrene?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Naval G. Parikh is classified as an Advanced expert for Gangrene, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Naval G. Parikh specialize in?

While Dr. Naval G. Parikh is a Internal Medicine, they have specific expertise in Gangrene, Stroke, and Gout. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Naval G. Parikh participate in research or clinical trials?

Yes. Dr. Naval G. Parikh has published 2 articles and abstracts on conditions like Gangrene. You can view a list of Dr. Naval G. Parikh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Naval G. Parikh accept my insurance?

Dr. Naval G. Parikh accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 954-933-7948 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Parikh's expertise for a condition
ConditionClose
      View All 68 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile